Yao, Wantong
The University of Texas MD Anderson Cancer Center
9 papers on CoChatORCID 0000-0002-0172-7530
Most cited papers
- Verified
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature
Pancreatic and Hepatic Oncology ResearchCancer, Hypoxia, and Metabolism
Cited by 1,259
- Verified
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
Kapoor, A., Yao, W., Ying, H., Hua, S., Liewen, A., Wang, Q., Zhong, Y., Wu, C.-J., Sadanandam, A., Hu, B., et al. (2014) · Cell
Hippo pathway signaling and YAP/TAZPancreatic and Hepatic Oncology Research
Cited by 716
- Verified
Genetics and biology of pancreatic ductal adenocarcinoma
Ying, H., Dey, P., Yao, W., Kimmelman, A. C., Draetta, G. F., Maitra, A., & DePinho, R. A. (2016) · Genes & Development
Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics
Cited by 527
- Verified
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer
Yao, W., Rose, J. L., Wang, W., Seth, S., Jiang, H., Taguchi, A., Liu, J., Yan, L., Kapoor, A., Hou, P., et al. (2019) · Nature
Pancreatic and Hepatic Oncology ResearchProteoglycans and glycosaminoglycans research
Cited by 214
- Verified
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors
Lv, X., Lu, X., Cao, J., Luo, Q., Ding, Y., Peng, F., Pataer, A., Lu, D., Han, D., Malmberg, E., et al. (2023) · Science
Endoplasmic Reticulum Stress and DiseaseProtein Kinase Regulation and GTPase Signaling
Cited by 123
- Verified
YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma
Tu, B., Yao, J., Ferri-Borgogno, S., Zhao, J., Chen, S., Wang, Q., Yan, L., Zhou, X., Zhu, C., Bang, S., et al. (2019) · JCI Insight
Hippo pathway signaling and YAP/TAZPancreatic and Hepatic Oncology Research
Cited by 75
- Verified
Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition
Yan, L., Tu, B., Yao, J., Gong, J., Carugo, A., Bristow, C. A., Wang, Q., Zhu, C., Dai, B., Kang, Y., et al. (2021) · Cancer Research
Pancreatic and Hepatic Oncology ResearchCancer, Hypoxia, and Metabolism
Cited by 48
- Verified
USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer
Hou, P., Ma, X., Yang, Z., Zhang, Q., Wu, C.-J., Li, J., Tan, L., Yao, W., Yan, L., Zhou, X., et al. (2021) · Genes & Development
Pancreatic and Hepatic Oncology ResearchUbiquitin and proteasome pathways
Cited by 35
- Verified
Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers
Theardy, M. S., Takeda, M., Sorokin, A., Chen, S., Yang, Z., Wang, X., Kanikarla, P., Coker, O., Nguyen, P., Wei, Y., et al. (2025) · Cell Reports Medicine
Protein Kinase Regulation and GTPase SignalingHippo pathway signaling and YAP/TAZ
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free